Tiotropium versus salmeterol for the prevention of exacerbations of COPD.
Por:
Vogelmeier C, Hederer B, Glaab T, Schmidt H, Rutten-van Mölken MP, Beeh KM, Rabe KF, Fabbri LM and POET-COPD Investigators
Publicada:
24 mar 2011
Categoría:
Medicine (miscellaneous)
Resumen:
Treatment guidelines recommend the use of inhaled long-acting bronchodilators to alleviate symptoms and reduce the risk of exacerbations in patients with moderate-to-very-severe chronic obstructive pulmonary disease (COPD) but do not specify whether a long-acting anticholinergic drug or a ß(2)-agonist is the preferred agent. We investigated whether the anticholinergic drug tiotropium is superior to the ß(2)-agonist salmeterol in preventing exacerbations of COPD.
Filiaciones:
Vogelmeier C:
Hospital of the Universities of Giessen and Marburg, Marburg, Germany
|